BridgeBio Pharma, Inc. (NASDAQ: BBIO) seems poised for a price surge based on its latest charts. The company discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

The commercial-stage biopharmaceutical company’s newly approved drug called Attruby has seen a substantial demand with 430 prescriptions from 248 unique healthcare providers.

Bullish Indications

#1 Breakout from Consolidation area: The daily chart shows that the stock had been consolidating within a price range for the past few days. This area is marked as a purple color rectangle. The stock has now broken out from this consolidation area with high volume and is currently trading above it. The breakout level of this consolidation area typically acts as a good support level.

BBIO – Daily Chart

#2 Price above MAs: The price is currently above the short-term moving average of 50-day SMA as well as the longer-term moving average of 200-day SMA, indicating that the bulls are still in control. This is a positive indication.

#3 MACD Above Signal Line: In the daily chart, the MACD line (light blue color) is currently above the MACD signal line (orange color) which is typically considered bullish.

#4 Bullish ADX: The ADX indicator shows that the +DI line is currently above the –DI line and the ADX line has started to move up from below the –DI and +DI lines. This indicates possible bullishness.

#5 Above Support Area: As you can see from the weekly chart, the stock has currently moved up from a resistance-turned-support level. This level is marked as a pink color dotted line. This looks like a good area for the stock to move higher. The stock is also trading above its 50-week and 200-week SMA, indicating that the bulls are firmly in control.

BBIO – Weekly Chart

#6 %K above %D: The %K (blue) line of stochastic has currently crossed above the %D (Orange) line in the weekly chart. This is a possible bullish indication.

#7 Bullish MACD: The MACD line is above the MACD signal line in the weekly chart as well, indicating bullishness.

Recommended Trade (based on the charts)

Buy Levels: If you want to get in on this trade, you can purchase shares of BBIO above the price of around $35.85.

TP: Our target prices are $42.00 and $45.00 in the next 3-6 months.

SL: To limit risk, place stop-loss at $33.00. Note that the stop-loss is on a closing basis.

Our target potential upside is 17% to 26% in the next 3 to 6 months.

For a risk of $2.85, our target rewards are $6.15 and $9.15. This is a nearly 1:2 and 1:3 risk-reward trade.

In other words, this trade offers nearly 2x to 3x more potential upside than downside.

Risks to Consider
The stock may reverse its overall trend if it breaks down from the consolidation area with a high volume. The sell-off of the stock could also be triggered in case of any negative news, overall weakness in the market, or any regulatory changes in the sector.

Happy Trading!

Tara

Former Wall Street Insider Calls This His Biggest Gold Play Yet [sponsor]
Karim Rahemtulla, the trader behind a 400% gain in 24-months on Rolls-Royce, has uncovered another potential multi-bagger. This under-$20 stock gives you exposure to over 1-oz of gold with the lowest production costs in the industry. And an upcoming announcement could send this stock soaring. Get Karim's urgent briefin - click here now.

Source: Trades of the Day